Emily Brook
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
- Barrier Structure and Function Studies
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
-
- Alzheimer's disease research and treatments 3
- Co-authors
- Arun Dharmarajan (4 shared papers)Crispin R. Dass (4 shared papers)Arlene Chan (4 shared papers)Naomi Brook (4 shared papers)Ryusuke Takechi (8 shared papers)Virginie Lam (8 shared papers)John Mamo (8 shared papers)Hani Al‐Salami (5 shared papers)
In The Last Decade
Emily Brook
15 papers receiving 520 citations
Peers
Comparison fields: 5 of 84
- Neurology 82
- Biological Psychiatry 13
- Oncology 85
- Physiology 76
- Pharmacology 40
Countries citing papers authored by Emily Brook
This map shows the geographic impact of Emily Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Brook more than expected).
Fields of papers citing papers by Emily Brook
This network shows the impact of papers produced by Emily Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Brook. The network helps show where Emily Brook may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Brook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 139 | |
| 2 | 2017 | 131 | |
| 3 | 2018 | 44 | |
| 4 | 2019 | 37 | |
| 5 | 2018 | 32 | |
| 6 | 2019 | 31 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 17 | |
| 9 | 2019 | 16 | |
| 10 | 2017 | 13 | |
| 11 | 2020 | 12 | |
| 12 | 2019 | 10 | |
| 13 | 2020 | 9 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 5 |
About Emily Brook
Emily Brook is a scholar working on Neurology, Physiology, Epidemiology, Molecular Biology and Pharmacology, having authored 15 papers that have together received 525 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Cannabis and Cannabinoid Research (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Corneal Surgery and Treatments (1 paper), Neuroscience and Neuropharmacology Research (1 paper), Retinoids in leukemia and cellular processes (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Neurology (82 citations), Biological Psychiatry (13 citations), Oncology (85 citations), Physiology (76 citations) and Pharmacology (40 citations). Emily Brook has collaborated with scholars based in Australia, India and Malaysia. Frequent co-authors include Arun Dharmarajan, Crispin R. Dass, Arlene Chan, Naomi Brook, Ryusuke Takechi, Virginie Lam, John Mamo, Hani Al‐Salami, Armin Mooranian and Michael Nesbit. Their work appears in journals such as Journal of Alzheimer s Disease, Pharmacological Research, Therapeutic Delivery, PLoS ONE and Clinical & Translational Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.